guru267 wrote:mwanahisa wrote:
I don't think this will last long. Prepare for the share to come down to the 27 - 30 range cum-rights and sub 25 after going ex-rights
@mwanahisa its these kind of predictions that make me wonder if calculators are standardized...
@g267, valuations are not based purely on intrinsic factors, and hence 2 analysts will arrive at different valuations depending on the weight they give to different considerations.
The cum-rights price for KPLC today ranged between 27 and 30 with an average price of 28. At 28, the weighted average of both the share and the right is Kshs 25.61; while at 27, it is 24.89, which is sub 25. If I can get the share at this price ex-rights, it means I will be indifferent between buying the share cum-rights or buying it ex-rights.
Any shareholder who manages to get an allocation that is disproportionate to their current holding will lower their cost to a price approaching the 19.50 price. What is to prevent such a shareholder from selling at 24 and taking a quick 20% profit? I believe that this will hold back the price for a while.
I however expect this scenario to change once the excess shares from the rights issue are mopped up through profit taking.
I think KenGen is valued at a much higher PE than KPLC, partly because of where the share price has come from - a high of 40+ at the IPO level. The bulk of non-IPO shareholders hold the share at a much higher price than today's price while IPO shareholders look at the price they could have sold it. That keeps the KenGen price much higher than it should be.